FDA · Class II · September 9, 2026

Baxter Healthcare recall: Vancomycin Injection and 10 more products

Baxter Healthcare Corporation is recalling Vancomycin Injection and 10 more products because of manufacturing-practice violations – N/A. The U.S. Food and Drug Administration published the recall on September 9, 2026; it began on August 6, 2026. Distributed nationwide.

Serious Class II means the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Illustration: A pharmacy dispensing machine – not the recalled product. Photo: U.S. Air Force / Airman Trevor Calvert, public domain.

Product	Vancomycin Injection and 10 more products
Brand	Baxter Healthcare
Company	Baxter Healthcare Corporation
Type	Drugs
Classification	Class II
Recall date	August 6, 2026
Published by FDA	September 9, 2026
Quantity	N/A
Recall ID	99500

As listed by FDA

Recalled products (17)

Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3552-48.
FDA recall number
D-0805-2026
Codes, lots and dates
Lot # NC188678, Exp Date: 12/1/2026; Lot # NC188814, Exp Date: 12/5/2026; Lot # NC188944, Exp Date: 12/8/2026; Lot # NC193610, Exp Date: 4/21/2027, Lot # NC193665, Exp Date: 4/23/2027.
Quantity
N/A
Classification
Class II
MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.
FDA recall number
D-0806-2026
Codes, lots and dates
Lot # NC188630, NC188708, NC188791, NC188845, NC188876, NC188968, Exp Date: 12/31/2027; Lot # NC193719, NC193849, Exp Date: 04/30/2028; Lot # NC194051, NC194105, Exp Date: 05/31/2028; Lot # NC195171, Exp Date: 06/30/2028.
Quantity
N/A
Classification
Class II
Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0714-24.
FDA recall number
D-0807-2026
Codes, lots and dates
Lot # NC188692, Exp Date: 11/22/2027.
Quantity
N/A
Classification
Class II
Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3612-50.
FDA recall number
D-0808-2026
Codes, lots and dates
Lot # NC193764, Exp Date: 10/18/2027; Lot # NC195232, Exp Date: 11/25/2027.
Quantity
N/A
Classification
Class II
Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only, Sterile Nonpyrogenic, Baxter International Inc., Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-5197-41.
FDA recall number
D-0809-2026
Codes, lots and dates
Lot # NC188586, Exp Date: 02/28/2027; Lot # NC188913, Exp Date: 3/9/2027.
Quantity
N/A
Classification
Class II
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Galaxy 100 mL Single Dose Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-9557-12.
FDA recall number
D-0810-2026
Codes, lots and dates
Lot # NC188654, Exp Date: 08/31/2027; Lot # NC188821, Exp Date: 09/30/2027; Lot # NC193658, NC193702, Exp Date: 01/31/2028.
Quantity
N/A
Classification
Class II
Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012 USA, NDC 0338-9640-12.
FDA recall number
D-0811-2026
Codes, lots and dates
Lot # NC193672, NC193795, Exp Date: 04/30/2028; Lot # NC194198, Exp Date: 05/31/2028.
Quantity
N/A
Classification
Class II
Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAXY Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, NDC 0338-9648-12.
FDA recall number
D-0812-2026
Codes, lots and dates
Lot # NC194129, Exp Date: 05/07/2028.
Quantity
N/A
Classification
Class II
CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10.
FDA recall number
D-0813-2026
Codes, lots and dates
Lot # NC177818, Exp Date: 12/31/2026; Lot # NC188869, Exp Date: 12/31/2027.
Quantity
N/A
Classification
Class II
Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Container, sterile, Nonpyrogenic, iso-osmotic solution in Dextrose, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in the USA, NDC 43066-360-20.
FDA recall number
D-0814-2026
Codes, lots and dates
Lot # NC177832, Exp Date: 12/31/2026; Lot # NC185417, NC185455, Exp Date: 08/31/2027; Lot # NC188593, Exp Date: 11/30/2027; Lot # NC188647, NC188685, NC188807, NC188838, NC188920, Exp Date: 12/31/2027; Lot # NC193603, NC193726, NC193788, NC193863, NC193900, Exp Date: 04/30/2028; Lot # NC194082, NC194112, NC194143, NC195157, Exp Date: 05/31/2028.
Quantity
N/A
Classification
Class II
Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3814-50.
FDA recall number
D-0815-2026
Codes, lots and dates
Lot # NC185424, Exp Date: 2/12/2027; Lot # NC185479, Exp Date: 2/13/2027; Lot # NC193948, Exp Date: 10/23/2027.
Quantity
N/A
Classification
Class II
Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-9549-50.
FDA recall number
D-0816-2026
Codes, lots and dates
Lot # NC193689, Exp Date: 10/16/2027.
Quantity
N/A
Classification
Class II
Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-4114-50.
FDA recall number
D-0817-2026
Codes, lots and dates
Lot # NC194075, Exp Date: 10/29/2027.
Quantity
N/A
Classification
Class II
Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-995-24.
FDA recall number
D-0818-2026
Codes, lots and dates
Lot # NC194068, Exp Date: 10/29/2027.
Quantity
N/A
Classification
Class II
Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-9647-12.
FDA recall number
D-0819-2026
Codes, lots and dates
Lot # NC185448, Exp Date: 8/31/2027; Lot # NC192910, Exp Date: 4/30/2028; Lot # NC195218, Exp Date: 6/30/2028.
Quantity
N/A
Classification
Class II
Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3583-01.
FDA recall number
D-0820-2026
Codes, lots and dates
Lot # NC193894, Exp Date: 04/25/2027.
Quantity
N/A
Classification
Class II
Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12.
FDA recall number
D-0821-2026
Codes, lots and dates
Lot # NC193856, Exp Date: 04/18/2028.
Quantity
N/A
Classification
Class II

Exactly as the agency lists them

Identifiers and details

FDA event ID: 99500
Initiated: Voluntary: Firm initiated
Status: Ongoing
Firm location: Deerfield, IL, United States

Why it was recalled

The problem: manufacturing-practice violations.

The reason the FDA lists: “CGMP Deviations”

Where it was sold

Nationwide. Distribution as the FDA records it: “US Nationwide; Puerto Rico; and Chile.”

What to do

Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.

Official notice: FDA Enforcement Report record (event 99500, openFDA) – the same recall numbers can be searched in the FDA Enforcement Report.

Same brand

Other Baxter Healthcare recalls

Date	Recall	Problem	Agency
Sep 30, 2026	Baxter Healthcare recall: Volara, HC, Na aMedical devices · 2	Contamination within the release test equipment flow path could have affected the accuracy… Serious	FDA Class II
Sep 30, 2026	Baxter Healthcare recall: Pro+ MRS Surface for Versacare and 2 more productsMedical devices · 169 units; 824 units; 6 units	There is an error in the product description on the Unique Device Identification (UDI) lab… Serious	FDA Class II
Sep 16, 2026	Baxter Healthcare recall: Dextrose InjectionDrugs · 606 bags	Presence of Particulate Matter: particulate matter identified as stainless steel particles… Most serious	FDA Class I
Sep 9, 2026	Baxter Healthcare recall: 0.9% Sodium Chloride Injection USPDrugs · 145,464 500mL bags	Presence of particulate matter: Particulates identified as fiberglass Most serious	FDA Class I
Sep 9, 2026	Baxter Healthcare recall: Baxter Novum IQ Syringe PumpMedical devices · 14601 units; 4 units	A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a s… Serious	FDA Class II
Aug 19, 2026	Baxter Healthcare recall: Baxter Duo-Vent Solution Set and Male Luer Lock AdapterMedical devices · 24528 units	Baxter received customer reports of air bubbles in the drip chamber and tubing when a pres… Most serious	FDA Class I
Aug 19, 2026	Baxter Healthcare recall: Cefazolin in DextroseDrugs · 19,032 bags	Presence of Particulate Matter Most serious	FDA Class I

All 8 Baxter Healthcare recalls →

FAQ

About this recall

Is Baxter Healthcare Vancomycin Injection recalled?

Yes. Baxter Healthcare Corporation recalled it on August 6, 2026; FDA published it September 9, 2026 (Class II). Only the lots, dates or models listed on this page are included.

Why was it recalled?

Because of manufacturing-practice violations. The reason given: CGMP Deviations

What should I do if I have it?

Where was it sold?

Nationwide.

Recalls

More recalls

Source: recall records published by the U.S. Food and Drug Administration (openFDA Enforcement Reports), the USDA Food Safety and Inspection Service, the Consumer Product Safety Commission and the National Highway Traffic Safety Administration, collected twice a day. Product names, lot codes, dates and model numbers are shown exactly as the agency lists them; the agency's notice is the authority. 77.today is not affiliated with any of these agencies.